Products
-
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensCell Lines for BBB Modeling
- Immortalized Cells for BBB ModelingPrimary Cells for BBB ModelingStem Cells for BBB ModelingProteins & Peptides for Stroke ResearchOnline Inquiry
Recombinant Human Eph Receptor A3 Protein (Fc Chimera 6xHis Tag) (AC1102)
Cat.#: ACPP-1102
Specifications
Despition Recombinant Human Eph Receptor A3 Protein (Fc Chimera 6xHis Tag) for ELISA, SDS-PAGE SIZE 50 µg Source Recombinant Protein Length Fragment Expression System HEK293 cells Protein Species Human Sequence EPHA3 (Glu21-Gln541) + mFc (Pro99-Lys330) + 6×His Tag Molecular Weight 85.9 kDa without signal peptide Purity > 95% by SDS-PAGE and Coomassie blue staining. Form Lyophilized Tag C-terminal Mouse Fc Tag and 6×His Tag Applications ELISA, SDS-PAGE Storage Lyophilized was stored at -20°C to -80°C, while reconstituted was aliquot and stored at -80°C. Avoid freeze/thaw cycles. Shipping Shipped at 4°C Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Size Price ACPP-1678 Human SDCBP Protein (AC1678) 5 µg inquiry ACPP-1348 Presenilin 1 Blocking Peptide (AC1348) 250 µg inquiry ACPP-1144 Synthetic Nanodisc Human GIPR Protein (AC1144) 10 µg inquiry ACPP-1340 PDE7A Blocking Peptide (AC1340) 250 µg inquiry ACPP-1081 Human NRN1 Protein (AC1081) 5 µg inquiry ACPP-1528 Human RCAN3 Protein (AC1528) 2 µg inquiry ACPP-1453 Human ACOT7 Protein (AC1453) 5 µg inquiry ACPP-1365 Progesterone Receptor Blocking Peptide (AC1365) 250 µg inquiry ACPP-1277 TSH beta Blocking Peptide (AC1277) 250 µg inquiry ACPP-1104 Human IL 6 Protein (AC1104) 5 µg inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
Quick Links0Inquiry Basket